<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02178293</url>
  </required_header>
  <id_info>
    <org_study_id>1087.7</org_study_id>
    <nct_id>NCT02178293</nct_id>
  </id_info>
  <brief_title>Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride</brief_title>
  <acronym>MISTRAL</acronym>
  <official_title>MISTRAL (Mouthwash In Sore Throat Relief: Antiinflammatory vs. Local Anesthetic Therapy) &quot;Efficacy and Tolerability of Ketoprofen Lysine Salt as a Mouthwash in Acute Phlogosis of the Pharyngeal Cavity; Multicentre, Randomized, Single-blind, Parallel-group Comparison Versus Benzidamine Hydrochloride&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      A study to in order to verify any differences between the 2 treatment groups in terms of
      duration of analgesic effects after the first drug intake and time to remission of symptoms
      and signs of pharyngitis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 1998</start_date>
  <primary_completion_date type="Actual">May 1999</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of analgesic effects in hours</measure>
    <time_frame>Up to 6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average number of days required to obtain remission of pain</measure>
    <time_frame>Up to day 8</time_frame>
    <description>day on which 2 consecutive pain measurements are both below 10 mm of the visual analog scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average severity of edema and hyperemia, assessed by investigator on a 4-point-scale</measure>
    <time_frame>Up to day 8</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">214</enrollment>
  <condition>Pharyngitis</condition>
  <arm_group>
    <arm_group_label>Benzidamine hydrochloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketoprofen lysine salt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzidamine hydrochloride</intervention_name>
    <arm_group_label>Benzidamine hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketoprofen lysine salt</intervention_name>
    <arm_group_label>Ketoprofen lysine salt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female outpatients, aged 18 to 70 years, suffering from acute pharyngitis,
             pharyngolaryngitis

          -  Moderately or severely intense pain in the pharyngeal region (score ≥ 70 mm) from the
             &quot;visual analogue scale&quot; (VAS)

          -  At least 1 of the 2 inflammation signs (edema and hyperemia) to be moderately or
             severely intense (score ≥ 2) from the scoring scale from 0 to 3

          -  Release of written informed consent by the patient

        Exclusion Criteria:

          -  Patients suffering from a microbial infection requiring specific antimicrobial
             treatment

          -  Patients who have taken the trial drugs during the week before enrolment

          -  Patients who have taken corticosteroids or antibiotics during the week before
             enrolment

          -  Ascertained or suspected hypersensitivity to trial drugs or to chemically correlated
             drugs or to other non-steroidal anti-inflammatory drugs or to mouthwashes in general

          -  Patients who are unable to properly fill in the diary every day as provided for by the
             protocol

          -  Ascertained or presumed pregnant or lactating women

          -  Inclusion in any other clinical trial during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2014</study_first_submitted>
  <study_first_submitted_qc>June 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2014</study_first_posted>
  <last_update_submitted>July 4, 2014</last_update_submitted>
  <last_update_submitted_qc>July 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Ketoprofen lysine</mesh_term>
    <mesh_term>Benzydamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

